A naturally inspired industrial biotechnology route to the manufacture of a novel biopolymer with unique properties

Synthmer和Ingenza将继续在TSB共同资助的一项成功的可行性研究中开始的合作。Synthmer已经确定了一种产品的市场缺口，如果使用工业生物技术制造这种产品，将会改善性能，并且没有现有制造技术制造的类似材料的缺点。他们预计，由于特性的改善，这种产品将迅速被吸收到他们的关键市场领域之一。Synthmer是全球前五大乳液和特种聚合物供应商，在这一目标市场拥有丰富的经验。Ingenza是一家生物技术推动者，他们使用专有技术开发新的生物工艺。Ingenza将通过创造一种能够制造Synthmer产品的转基因微生物来开发一种生物工艺。在该计划成功完成后，Synthmer和Ingenza希望进行持久的合作，为这一独特的产品优化可持续的制造生物工艺。

Synthomer and Ingenza will continue the collaboration begun in a successful TSB co-funded Feasibility Study. Synthomer have identified a market gap for a product which if made using industrial biotechnology would have improved properties and none of the drawbacks of similar materials made by existing manufacturing technologies. They anticipate that this product would be rapidly assimilated into one of their key market areas due the improved characteristics. Synthomer are a top 5 global supplier of emulsion and specialty polymer company with vast experience in this target market. Ingenza are a biotechnology enabler who develop novel bioprocesses using proprietary technologies. Ingenza will develop a bioprocess by creating a GM microorganism capable of manufacturing Synthomer's product. Following the successful completion of the programme, Synthomer and Ingenza expect to enter into a lasting collaboration to optimise a sustainable manufacturing bioprocess for this unique product.